
DLBCL and Follicular Lymphoma Clinical Trials at MD Anderson
May 03, 2024
05:00PM EDT
Online Event
Dr. Strati, a lymphoma specialist from MD Anderson, joins HealthTree to discuss the recent DLBCL and follicular lymphoma trials he has been working on. This Podcast episode will include the discussion of the completed phase I study of evorpacept and R2 in relapsed indolent B-NHL, the completed phase 2 study of acalabrutinib and R2 in previously untreated indolent B-NHL, the ongoing phase 2 study of loncastuximab as consolidation after CART in DLBCL, and the upcoming phase 2 study of emapalaumab for the treatment of persistent severe cytopenia after CART in DLBCL. Join us to hear the exciting updates on these trials and how you can participate.

Dr. Paolo Strati

Kat Richardson